Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals

Use Our Content This story can be republished for free (details). Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs. But the administration’s plan for drug rebates, announced Thursday, would end the pharmaceutical business as usual, shift billions in revenue and… Read More »

eMDs acquires Aprima, boosting outpatient EHR offerings

Electronic health record developer eMDs is acquiring Aprima Medical Software for an undisclosed sum. The addition of Aprima, which develops EHR, practice management and revenue cycle management technology, will help eMDs better serve its 63,000 provider customers worldwide, the company said. WHY IT MATTERSBoth companies had independently worked on modernizing their product lines before this… Read More »

FDA declines to approve Alkermes opioid-based depression drug

(Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc’s opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug. The largely expected decision comes months after an advisory panel to the FDA strongly voted against the drug and raised questions on its safety… Read More »